A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients
NCT01672762
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
174
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
ipragliflozin
Sponsor
Astellas Pharma Inc